These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34830633)

  • 21. Clot Waveform Analysis: From Hypercoagulability to Hypocoagulability - A Review.
    Marongiu F; Ruberto MF; Marongiu S; Barcellona D
    Arch Pathol Lab Med; 2024 Feb; ():. PubMed ID: 38375736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Clot Waveform Analysis of Thrombin Time Using a Small Amount of Thrombin Is Useful for Evaluating the Clotting Activity of Plasma Independent of the Presence of Emicizumab.
    Wada H; Shiraki K; Matsumoto T; Suzuki K; Yamashita Y; Tawara I; Shimpo H; Shimaoka M
    J Clin Med; 2022 Oct; 11(20):. PubMed ID: 36294464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance and Interpretation of Clot Waveform Analysis.
    Ruberto MF; Marongiu F; Barcellona D
    Methods Mol Biol; 2023; 2663():163-173. PubMed ID: 37204709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clot Waveform Analysis for Monitoring Hemostasis.
    Nogami K
    Semin Thromb Hemost; 2023 Sep; 49(6):592-599. PubMed ID: 36174610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Reevaluation of Thrombin Time Using a Clot Waveform Analysis.
    Wada H; Ichikawa Y; Ezaki M; Matsumoto T; Yamashita Y; Shiraki K; Shimaoka M; Shimpo H
    J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A correlation of thrombin generation assay and clot waveform analysis in patients on warfarin.
    Cheong MA; Tan CW; Wong WH; Kong MC; See E; Yeang SH; Koh SK; Shim YT; Lee LH; Ng HJ
    Hematology; 2022 Dec; 27(1):337-342. PubMed ID: 35255239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of the phenotypic severity of hemophilia A: using rotational thromboelastometry (ROTEM) and APTT-clot waveform analysis.
    Gupta D; Arya V; Dass J; Gupta N; Kalra M; Sachdeva A; Kotwal J
    Blood Res; 2024 May; 59(1):19. PubMed ID: 38743166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of aPTT-based clot waveform analysis for the detection of haemostatic changes in different types of infections.
    Tan CW; Wong WH; Cheen MHH; Chu YMH; Lim SS; Ng LCK; Yeo DGD; Morvil G; Lee LH; Ng HJ
    Sci Rep; 2020 Aug; 10(1):14186. PubMed ID: 32843693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of in vitro effects of direct thrombin inhibitors and activated factor X inhibitors through clot waveform analysis.
    Wakui M; Fujimori Y; Katagiri H; Nakamura S; Kondo Y; Kuroda Y; Nakagawa T; Shimizu N; Murata M
    J Clin Pathol; 2019 Mar; 72(3):244-250. PubMed ID: 30518630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening of the protein C pathway abnormality-related thrombophilia by using thrombomodulin-mediated tissue factor-triggered clot waveform analysis.
    Hashimoto N; Ogiwara K; Shimonishi N; Nakagawa T; Nakajima Y; Furukawa S; Takeyama M; Nogami K
    Eur J Haematol; 2022 Jul; 109(1):100-108. PubMed ID: 35430749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective comparison of standard clotting tests and novel clot waveform parameters in dogs using the turbidimetric ACL-TOP CTS 300 coagulation analyzer.
    Yagneswar H; Todd JM; Sharkey LC; Rendahl A; Tart K
    J Vet Diagn Invest; 2018 Nov; 30(6):868-877. PubMed ID: 30204058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clot wave analysis and thromboembolic score in liver cirrhosis: two opposing phenomena.
    Ruberto MF; Sorbello O; Civolani A; Barcellona D; Demelia L; Marongiu F
    Int J Lab Hematol; 2017 Aug; 39(4):369-374. PubMed ID: 28422416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overall hemostasis potential and aPTT-clot waveform analysis as powerful laboratory diagnostic tools for identification of hemophilia A patients with unexpected bleeding phenotype.
    Milos M; Coen Herak D; Mahmoud Hourani Soutari N; Pavic J; Zupancic-Salek S; Zadro R; Antovic JP
    Int J Lab Hematol; 2021 Apr; 43(2):273-280. PubMed ID: 32964648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The venous thromboembolic risk and the clot wave analysis: a useful relationship?
    Ruberto MF; Marongiu F; Mandas A; Mameli A; Porru M; Cianchetti E; Barcellona D
    Clin Chem Lab Med; 2018 Feb; 56(3):448-453. PubMed ID: 29031015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct features of bivalent direct thrombin inhibitors, hirudin and bivalirudin, revealed by clot waveform analysis and enzyme kinetics in coagulation assays.
    Wakui M; Fujimori Y; Nakamura S; Kondo Y; Kuroda Y; Oka S; Nakagawa T; Katagiri H; Murata M
    J Clin Pathol; 2019 Dec; 72(12):817-824. PubMed ID: 31366633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterisation of antithrombin-dependent anticoagulants through clot waveform analysis to potentially distinguish them from antithrombin-independent inhibitors targeting activated coagulation factors.
    Wakui M; Fujimori Y; Nakamura S; Oka S; Ozaki Y; Kondo Y; Nakagawa T; Katagiri H; Murata M
    J Clin Pathol; 2021 Apr; 74(4):251-256. PubMed ID: 32796051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal wavelength for the clot waveform analysis: Determination of the best resolution with minimal interference of the reagents.
    Evrard J; Siriez R; Morimont L; Thémans P; Laloy J; Bouvy C; Gheldof D; Mullier F; Dogné JM; Douxfils J
    Int J Lab Hematol; 2019 Jun; 41(3):316-324. PubMed ID: 30730600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrospective evaluation of shortened prothrombin time or activated partial thromboplastin time for the diagnosis of hypercoagulability in dogs: 25 cases (2006-2011).
    Song J; Drobatz KJ; Silverstein DC
    J Vet Emerg Crit Care (San Antonio); 2016 May; 26(3):398-405. PubMed ID: 27074596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monitoring of hemostatic abnormalities in major orthopedic surgery patients treated with edoxaban by APTT waveform.
    Hasegawa M; Wada H; Tone S; Yamaguchi T; Wakabayashi H; Ikejiri M; Watanabe M; Fujimoto N; Matsumoto T; Ohishi K; Yamashita Y; Katayama N; Sudo A
    Int J Lab Hematol; 2018 Feb; 40(1):49-55. PubMed ID: 28869359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated Plasma Factor IXa Activity in Premenopausal Women on Hormonal Contraception.
    Tanratana P; Ellery P; Westmark P; Mast AE; Sheehan JP
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):266-274. PubMed ID: 29097362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.